Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Dec;120(12):1370-4.
doi: 10.1001/archotol.1994.01880360066012.

Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement

Affiliations

Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement

K D Olsen et al. Arch Otolaryngol Head Neck Surg. 1994 Dec.

Abstract

Objective: Retrospectively analyze several histopathologic variables that may predict neck recurrence after neck dissection.

Design: From 1970 through 1980, 284 patients with pathologically confirmed metastatic squamous cell carcinoma underwent neck dissection and received no adjuvant therapy. Kaplan-Meier evaluation estimated a 74% 2-year neck recurrence-free rate. After adjusting for the standard covariates of age, gender, neck stage, and tumor grade, we also controlled for the time-dependent covariates of primary recurrence, occurrence in the side of the neck not operated on, or development of new head and neck primary disease.

Setting: A large referral-based practice.

Results: The number of lymph nodes involved, invasion of vascular/lymphatic space, invasion of soft tissue, and desmoplastic lymph node pattern adversely affect neck recurrence. A desmoplastic stromal pattern was associated with almost a sevenfold increased risk of neck recurrence. To our knowledge, this finding has not been reported previously.

Conclusion: Histopathologic evaluation of metastatically involved cervical nodes can identify patients with head and neck cancer who are at high risk for recurrence.

PubMed Disclaimer

MeSH terms

LinkOut - more resources